Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae
- PMID: 1291320
- DOI: 10.1007/BF01961143
Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae
Abstract
The activity of meropenem against 106 imipenem-resistant (MIC > or = 8 mg/l) clinical isolates, and the frequency of resistance to meropenem and imipenem among 24 Enterobacteriaceae was determined. Both agents selected colonies on agar but 20-80% were susceptible after one subculture and 72% of the mutants reverted to susceptibility 1 to 6 months after selection. All isolates and stable mutants were inhibited by > 1 mg/l meropenem, although the MIC of imipenem was 4-16 mg/l. Three of six Xanthomonas maltophilia isolates were susceptible to meropenem (MICs 2-4 mg/l). Pseudomonas aeruginosa lacking outer membrane protein D2 were resistant to meropenem, although isolates with substantially reduced expression of this protein were susceptible. None of the imipenem-resistant gram-positive bacteria were susceptible to meropenem. There was no clear correlation between altered outer membrane protein expression and decreased susceptibility to carbapenems, and there was no apparent involvement of plasmid or chromosomal beta-lactamase.
Similar articles
-
Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.J Antimicrob Chemother. 1989 Sep;24 Suppl A:187-96. doi: 10.1093/jac/24.suppl_a.187. J Antimicrob Chemother. 1989. PMID: 2808207
-
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.J Antimicrob Chemother. 1989 Sep;24 Suppl A:133-41. doi: 10.1093/jac/24.suppl_a.133. J Antimicrob Chemother. 1989. PMID: 2808205
-
[in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].Enferm Infecc Microbiol Clin. 1997 Sep;15 Suppl 1:20-6. Enferm Infecc Microbiol Clin. 1997. PMID: 9410065 Spanish.
-
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9. Drugs. 2018. PMID: 29230684 Review.
-
Bacterial resistance: a worldwide problem.Diagn Microbiol Infect Dis. 1998 Jun;31(2):379-88. doi: 10.1016/s0732-8893(98)00037-6. Diagn Microbiol Infect Dis. 1998. PMID: 9635913 Review.
Cited by
-
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.Clin Microbiol Rev. 1998 Jan;11(1):57-80. doi: 10.1128/CMR.11.1.57. Clin Microbiol Rev. 1998. PMID: 9457429 Free PMC article. Review.
-
Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select.Antimicrob Agents Chemother. 2011 Apr;55(4):1332-7. doi: 10.1128/AAC.01222-10. Epub 2011 Jan 24. Antimicrob Agents Chemother. 2011. PMID: 21263047 Free PMC article.
-
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):82-5. doi: 10.1007/BF01586192. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8641311
-
Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.J Clin Microbiol. 2003 Jan;41(1):351-8. doi: 10.1128/JCM.41.1.351-358.2003. J Clin Microbiol. 2003. PMID: 12517872 Free PMC article.
-
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.Antimicrob Agents Chemother. 1999 Jul;43(7):1669-73. doi: 10.1128/AAC.43.7.1669. Antimicrob Agents Chemother. 1999. PMID: 10390220 Free PMC article.